The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present

A Severe Adverse Effect of Atomoxetine

(2020) Gokce Guldiken et al.   CLINICAL NEUROPHARMACOLOGY

Pharmacotherapy of restricted/repetitive behavior in autism spectrum disorder:a systematic review and meta-analysis

(2020) Yanjie Yu et al.   BMC Psychiatry

Severe movement disorder and psychosis from haloperidol withdrawal in a 7‐year‐old girl with autism

(2020) Suma Syamkumar et al.   JOURNAL OF PAEDIATRICS AND CHILD HEALTH

Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder

(2020) Deborah A. Pearson et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial

(2019) C. Lindsay DeVane et al.   PHARMACOTHERAPY

Raynaud's Phenomenon Related with Atomoxetine Treatment in a Child with Autism and Attention-Deficit/Hyperactivity Disorder

(2019) Zeynep Nur Gülle et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: A cross-sectional study

(2019) Laura Fusar-Poli et al.   PSYCHIATRY RESEARCH

Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis

(2019) Celso Arango et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders

(2019) Dinah S. Reddihough et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder

(2019) Laura A. Potter et al.   Frontiers in Psychiatry

Atomoxetine, Parent Training, and Their Effects on Sleep in Youth with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder

(2018) Jill A. Hollway et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism

(2018) L. Eugene Arnold et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures

(2018) Laura C. Politte et al.   NEUROPSYCHOPHARMACOLOGY

Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights

(2018) Itaru Kushima et al.   Cell Reports

Treatment of catatonia in autism spectrum disorders

(2018) L. E. Wachtel   ACTA PSYCHIATRICA SCANDINAVICA

Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline

(2017) Jessica A. Hellings et al.   EXPERT OPINION ON PHARMACOTHERAPY

Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism

(2017) Rameshwari V. Tumuluru et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder

(2017) Lawrence Scahill et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor

(2017) Benjamin Adam Samuels et al.   NEUROPSYCHOPHARMACOLOGY

An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan

(2017) Hironobu Ichikawa et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia

(2017)   Molecular Autism

Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review

(2016) K. Jobski et al.   ACTA PSYCHIATRICA SCANDINAVICA

Initial severity and efficacy of risperidone in autism: Results from the RUPP trial

(2016) S.Z. Levine et al.   EUROPEAN PSYCHIATRY

No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder

(2016) Lan Chi Vo et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey

(2016) Ozhan Yalcin et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome

(2016) Laura Greiss Hess et al.   JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS

Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial

(2016) Diane C. Chugani et al.   JOURNAL OF PEDIATRICS

BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents

(2016) Aditya N Sharma et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study

(2016) Tristram Smith et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder

(2016) Lawrence Scahill et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder

(2016) Anjali L. Varigonda et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Autism spectrum disorder and attention-deficit/hyperactivity disorder in early childhood: A review of unique and shared characteristics and developmental antecedents

(2016) Janne C. Visser et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Sleep Difficulties and Medications in Children With Autism Spectrum Disorders: A Registry Study

(2016) B. A. Malow et al.   PEDIATRICS

Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review

(2016) Allison Beck Blackmer et al.   PHARMACOTHERAPY

Using venlafaxine to treat behavioral disorders in patients with autism spectrum disorder

(2016) Giuliana Galli Carminati et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study

(2016) Marco Lamberti et al.   PEDIATRIC DRUGS

Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics

(2016) Britta Galling et al.   JAMA Psychiatry

Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder

(2015) Lawrence Scahill et al.   AMERICAN JOURNAL OF PSYCHIATRY

Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports

(2015) Sylvie Serret et al.   BMC Psychiatry

Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders

(2015) Roberto Canitano   CLINICAL NEUROPHARMACOLOGY

N-Acetylcysteine as an Adjunctive Therapy to Risperidone for Treatment of Irritability in Autism

(2015) Mohammadali Nikoo et al.   CLINICAL NEUROPHARMACOLOGY

Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives

(2015) Antonio M. Persico et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The pharmacodynamic properties of lurasidone and their role in its antidepressant efficacy in bipolar disorder

(2015) Konstantinos N. Fountoulakis et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Low Dose Loxapine: Neuromotor Side Effects and Tolerability in Autism Spectrum Disorders

(2015) Jessica A. Hellings et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder

(2015) Kelli Dominick et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

No Evidence for Predictors of Response to Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents with Autism Spectrum Disorder

(2015) Myriam Harfterkamp et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Loxapine Add-on for Adolescents and Adults with Autism Spectrum Disorders and Irritability

(2015) Jessica A. Hellings et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial

(2015) Michael Aman et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Parental Stress in Families of Children With Autism and Other Developmental Disabilities

(2015) Maria Valicenti-McDermott et al.   JOURNAL OF CHILD NEUROLOGY

Iron Homeostasis During Risperidone Treatment in Children and Adolescents

(2015) Chadi A. Calarge et al.   JOURNAL OF CLINICAL PSYCHIATRY

Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder

(2015) Benjamin L. Handen et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

A Randomized Double-Blind Placebo-Controlled Clinical Trial of Adjuvant Buspirone for Irritability in Autism

(2015) Ahmad Ghanizadeh et al.   PEDIATRIC NEUROLOGY

A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism

(2015) Ali Ghaleiha et al.   PSYCHIATRY RESEARCH

Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis

(2014) Stefano Gabriele et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Atomoxetine in Autism Spectrum Disorder: No Effects on Social Functioning; Some Beneficial Effects on Stereotyped Behaviors, Inappropriate Speech, and Fear of Change

(2014) Myriam Harfterkamp et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Body Mass Index Change in Autism Spectrum Disorders: Comparison of Treatment with Risperidone and Aripiprazole

(2014) Logan K. Wink et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Preliminary Investigation of Lithium for Mood Disorder Symptoms in Children and Adolescents with Autism Spectrum Disorder

(2014) Matthew Siegel et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A Randomized Controlled Trial Investigating the Safety and Efficacy of Aripiprazole in the Long-Term Maintenance Treatment of Pediatric Patients With Irritability Associated With Autistic Disorder

(2014) Robert L. Findling et al.   JOURNAL OF CLINICAL PSYCHIATRY

Mechanisms of Levetiracetam in the Control of Status Epilepticus and Epilepsy

(2014) Laxmikant S. Deshpande et al.   Frontiers in Neurology

Effectiveness and Tolerability of Switching to Aripiprazole From Risperidone in Subjects With Autism Spectrum Disorders

(2013) Makoto Ishitobi et al.   CLINICAL NEUROPHARMACOLOGY

Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms

(2013) Pavel Golubchik et al.   CLINICAL NEUROPHARMACOLOGY

Double-Blind, Placebo-Controlled Trial of Risperidone Plus Amantadine in Children With Autism

(2013) Mohammad-Reza Mohammadi et al.   CLINICAL NEUROPHARMACOLOGY

Five-Fold Increase in National Prevalence Rates of Attention-Deficit/Hyperactivity Disorder Medications for Children and Adolescents with Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and other Psychiatric Disorders: A Danish Register-Based Study

(2013) Søren Dalsgaard et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

An Open-Label Extension Study of the Safety and Efficacy of Risperidone in Children and Adolescents with Autistic Disorder

(2013) Justine M. Kent et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Long-Term Treatment with Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents with Autism Spectrum Disorder: An Open-Label Extension Study

(2013) Myriam Harfterkamp et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Aripiprazole Treatment of Irritability Associated with Autistic Disorder and the Relationship Between Prior Antipsychotic Exposure, Adverse Events, and Weight Change

(2013) Raymond Mankoski et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Effects of Extended Release Methylphenidate Treatment on Ratings of Attention-Deficit/Hyperactivity Disorder (ADHD) and Associated Behavior in Children with Autism Spectrum Disorders and ADHD Symptoms

(2013) Deborah A. Pearson et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A Randomized, Double-Blind Comparison of Atomoxetine and Placebo on Response Inhibition and Interference Control in Children and Adolescents With Autism Spectrum Disorder and Comorbid Attention-Deficit/Hyperactivity Disorder Symptoms

(2013) Jolanda M.J. van der Meer et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders

(2013) Laura C. Politte et al.   PSYCHOPHARMACOLOGY

Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study

(2013) Yingfen Hsia et al.   PSYCHOPHARMACOLOGY

Baseline Factors Predicting Placebo Response to Treatment in Children and Adolescents With Autism Spectrum Disorders

(2013) Bryan H. King et al.   JAMA Pediatrics

Effect of Aripiprazole 2 to 15 mg/d on Health-Related Quality of Life in the Treatment of Irritability Associated with Autistic Disorder in Children: A Post Hoc Analysis of Two Controlled Trials

(2012) James W. Varni et al.   CLINICAL THERAPEUTICS

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial

(2012) Ali Ghaleiha et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability

(2012) Emily Simonoff et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

Research Units of Pediatric Psychopharmacology (RUPP) Autism Network Randomized Clinical Trial of Parent Training and Medication: One-Year Follow-Up

(2012) L. Eugene Arnold et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

A Randomized Double-Blind Study of Atomoxetine Versus Placebo for Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Autism Spectrum Disorder

(2012) Myriam Harfterkamp et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Levetiracetam-Induced Reversible Autistic Regression

(2012) Ana Camacho et al.   PEDIATRIC NEUROLOGY

Epidemiology of Autism Spectrum Disorders in Adults in the Community in England

(2011) Traolach S. Brugha et al.   ARCHIVES OF GENERAL PSYCHIATRY

Low-Dose Quetiapine for Adolescents With Autistic Spectrum Disorder and Aggressive Behavior

(2011) Pavel Golubchik et al.   CLINICAL NEUROPHARMACOLOGY

Safety and Tolerability of Aripiprazole for Irritability in Pediatric Patients With Autistic Disorder

(2011) Ronald N. Marcus et al.   JOURNAL OF CLINICAL PSYCHIATRY

Retrospective Review of Clozapine in the Treatment of Patients With Autism Spectrum Disorder and Severe Disruptive Behaviors

(2011) Laurène Beherec et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Autism Spectrum Disorders and Health Care Expenditures

(2011) Georgina Peacock et al.   JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS

Effects of Risperidone and Parent Training on Adaptive Functioning in Children With Pervasive Developmental Disorders and Serious Behavioral Problems

(2011) Lawrence Scahill et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Effects of fluoxetine treatment in young children with idiopathic autism

(2010) G Robert DeLong et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Line-Item Analysis of the Aberrant Behavior Checklist: Results from Two Studies of Aripiprazole in the Treatment of Irritability Associated with Autistic Disorder

(2010) Michael G. Aman et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

fMRI tracks reductions in repetitive behaviors in autism: Two case studies

(2010) Gabriel S. Dichter et al.   NEUROCASE

Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder

(2010) Vala Rezaei et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models

(2010) Jue He et al.   Cell Adhesion & Migration

Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior

(2009) Bryan H. King et al.   ARCHIVES OF GENERAL PSYCHIATRY

Aripiprazole Monotherapy in Children and Young Adolescents with Pervasive Developmental Disorders

(2009) Gabriele Masi et al.   CNS DRUGS

Olanzapine compared to quetiapine in adolescents with a first psychotic episode

(2009) Celso Arango et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Effectiveness of Mirtazapine in the Treatment of Inappropriate Sexual Behaviors in Individuals with Autistic Disorder

(2009) Murat Coskun et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Randomized, Placebo-Controlled, Crossover Study of Methylphenidate for Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers with Developmental Disorders

(2009) Jaswinder K. Ghuman et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

The Child Behavior Checklist-Pediatric Bipolar Disorder Profile Predicts a Subsequent Diagnosis of Bipolar Disorder and Associated Impairments in ADHD Youth Growing Up

(2009) Joseph Biederman et al.   JOURNAL OF CLINICAL PSYCHIATRY

Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial

(2009) Michael G. Aman et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation

(2009) B S McEwen et al.   MOLECULAR PSYCHIATRY

Divalproex Sodium vs Placebo for the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorders

(2009) Eric Hollander et al.   NEUROPSYCHOPHARMACOLOGY

Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder

(2009) R. Owen et al.   PEDIATRICS

Use of clonidine in children with autism spectrum disorders

(2008) Xue Ming et al.   BRAIN & DEVELOPMENT

Cognitive Effects of Risperidone in Children with Autism and Irritable Behavior

(2008) Michael G. Aman et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Guanfacine in Children with Autism and/or Intellectual Disabilities

(2008) Benjamin L. Handen et al.   JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS